Atom Bioscience
@atombp.com
Now Recruiting in Cary, North Carolina:Clinical Trial for Gout Treatment Atom Therapeutics is pleased to announce that we are actively recruiting participants in the Cary, NC area for a clinical study evaluating our investigational therapy ABP-671 (lingdolinurad) in combination with allopurinol. This study is focused on advancing treatment options for individuals living with chronic gout and acute gout, aiming to assess […]
Atom Bioscience's Company Logos
Atom Bioscience's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D52222
Alizarin Crimson
213, 34, 34
0, 72, 48
0, 84, 84, 16
#C4C4C4
Silver
196, 196, 196
0, 0, 77
0, 0, 0, 23
#333333
Mine Shaft
51, 51, 51
0, 0, 20
0, 0, 0, 80
About Atom Bioscience
Atom Bioscience & Pharmaceutical is a research-driven pharmaceutical company dedicated to the development of innovative drugs for inflammatory and metabolic diseases. One of our current developments is ABP-671, an innovative drug for the treatment of gout. ABP-671 has completed Phase 1 clinical trials in the United States and Phase 2a clinical trials in Australia.
We are now advancing ABP-671 to global Phase 3 clinical trials and commercialization. We are also conducting preclinical research on ABP-6016, another innovative drug targeting NASH and other conditions. Our management team and advisory team consist of experienced professionals in the field, ensuring the highest level of expertise in drug development.
Atom Bioscience & Pharmaceutical has received significant funding since 2012 and completed a successful C-round financing in December 2021. With our dedication to innovation, we strive to make a significant impact on the field of bioscience and pharmaceuticals
